Provided by Tiger Trade Technology Pte. Ltd.

Regencell Bioscience Limited

6.22
+0.02000.32%
Post-market: 6.220.00000.00%19:51 EDT
Volume:56.13K
Turnover:348.03K
Market Cap:3.08B
PE:-436.37
High:6.25
Open:6.24
Low:6.14
Close:6.20
52wk High:69.00
52wk Low:4.51
Shares:494.49M
Float Shares:18.43M
Volume Ratio:0.69
T/O Rate:0.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0143
EPS(LYR):-0.0072
ROE:-177.66%
ROA:-84.97%
PB:2522.36
PE(LYR):-858.17

Loading ...

Oculis Announces Positive FDA Pre-IND Feedback Supporting Privosegtor Development Strategy for Treatment of Acute Multiple Sclerosis Relapses

GlobeNewswire
·
Aug 03

Regencell Bioscience rises 25.2%

TIPRANKS
·
Jul 09

Regencell Bioscience Holdings (RGC) Faces DOJ Scrutiny, Is The Stock Too Expensive?

Simply Wall St.
·
Jul 06

Regencell Bioscience rises 29.6%

TIPRANKS
·
Jul 02

Regencell Bioscience falls -13.6%

TIPRANKS
·
Jun 26

Regencell Bioscience falls -14.3%

TIPRANKS
·
Jun 25

S&P 500 Futures Decline In Premarket Trading; Primoris Services, Tower Semiconductor Lag

Dow Jones
·
Jun 23

Regencell Bioscience falls -14.7%

TIPRANKS
·
Jun 18

Regencell Bioscience Holdings (RGC) Stock Valuation After Securities Class Action Raises Fresh Concerns

Simply Wall St.
·
Jun 16

Regencell Bioscience Holdings (RGC) Is Down 11.5% After DOJ Subpoena Spurs Class Actions Over Alleged Misstatements – Has The Bull Case Changed?

Simply Wall St.
·
Jun 10

A Look At Regencell Bioscience Holdings (RGC) Valuation After DOJ Subpoena And Shareholder Class Actions

Simply Wall St.
·
Jun 05

RGC Resources Establishes New $15 Million Term Loan

TIPRANKS
·
Jun 05

Zscaler, AutoZone, And Regencell Are Among Top 10 Large-Cap Losers Last Week (May 25-May 29): Are The Others In Your Portfolio?

Benzinga
·
May 31

Regencell Bioscience closes USD 20 million registered direct share offering

Reuters
·
May 22

Regencell Bioscience faces shareholder class action over alleged stock manipulation risks

Reuters
·
May 21

RGC Resources Balances Earnings Strength and New Risks

TIPRANKS
·
May 20

Regencell Bioscience prices 985,222-share registered direct offering at $20.30 per share

Reuters
·
May 19

Regencell FY26 H1 net loss widens 187% to $5.3 million

Reuters
·
May 09

Regencell Bioscience Holdings Faces Federal Securities Lawsuit Over Alleged Market Manipulation Disclosures

TIPRANKS
·
May 07

Regencell Bioscience Holdings Faces Investor Lawsuit Alleging Securities Fraud Tied to DOJ Investigation and Stock Volatility

TIPRANKS
·
May 02